Summary
Tremor induced by thiophene-2-aldoxime is enhanced or reduced in intensity and duration by agents which respectively interfere with or promote dopaminergic tone.
Similar content being viewed by others
References
N. R. Banna and R. Kurkjian, Brain Res.87, 114 (1975).
G. M. Everett, Nature177, 1238 (1956).
J. M. Van Rossum, Int. Rev. Neurobiol.12, 307 (1970).
N.-E. Andén, A. Rubenson, K. Fuxe and T. Hokfelt, J. Pharm. Pharmac.19, 627 (1967).
N.-E. Andén, S. Butcher, H. Corrodi, K. Fuxe and U. Ungerstedt, Eur. J. Pharmac.11, 303 (1970).
Author information
Authors and Affiliations
Additional information
This project was supported by a grant from the Lebanese National Research Council. We thank the following companies for the indicated drugs: Abbott (pargyline), Specia (chlorpromazine), Squibb (cinanserin).
Rights and permissions
About this article
Cite this article
Kurkjian, R., Banna, N.R. Dopaminergic mechanisms in thiophene-2-aldoxime tremor. Experientia 38, 841–842 (1982). https://doi.org/10.1007/BF01972305
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01972305